Dudediligence.

Tyra Biosciences, Inc

TYRANASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$24.0MSep ’24−$25.6MDec ’24−$28.1MMar ’25−$28.1MJun ’25−$29.9MSep ’25−$33.8MDec ’25−$39.3MMar ’26−$45.6MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating income−$26.3M−$58.9M−$79.9M−$104.2M−$132.8M
Net income−$26.3M−$55.3M−$69.1M−$86.5M−$119.9M
Operating cash flow−$23.7M−$50.3M−$50.1M−$69.8M−$95.1M
Free cash flow−$24.4M−$50.8M−$50.9M−$70.4M−$95.3M
Cash$302.2M$251.2M$58.0M$92.0M$77.4M
Shares outstanding41.4M42.4M43.0M50.7M53.7M